|
Daily Medical Update
Carbon monoxide poisoning
Wednesday, July 29, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
International journal of occupational medicine and environmental health (2025) - Practice Guideline
Key Findings
- Immediate normobaric oxygen therapy with 100% oxygen at the highest feasible flow, preferably by non-rebreather mask, is recommended as the treatment cornerstone.
- Oxygen should continue until COHb is approximately 3% and for no less than 6 hours, with extended oxygen therapy recommended for pregnant patients.
- HBOT selection increases for persistent neurologic or cardiac symptoms or metabolic acidosis despite normobaric oxygen, and is indicated in 100% of pregnant patients regardless of COHb level or presentation.
📋 Practice Implication: Emergency protocols should default to aggressive early normobaric oxygen while reserving HBOT decisions for explicit neurologic, cardiac, metabolic, and pregnancy criteria rather than COHb alone.
|
The Indian journal of medical research (2026) - Retrospective Cohort Study
Key Findings
- Among 124 patients, acidosis was associated with an increased ICU admission rate of 44.8% versus 17.7% with normal pH and 12.5% with alkalemia.
- The acidosis group had increased metabolic disturbance, including median lactate 7.60 mmol/L and median GCS 7.
- GCS score, COHb, arterial lactate, and HCO3 increased prediction of ICU admission as independent severity markers.
📋 Practice Implication: Initial triage should include arterial blood gas assessment, especially pH, lactate, and bicarbonate, to identify severe poisoning that COHb measurement alone may understate.
|
Journal of clinical medicine (2026) - Cohort Study
Key Findings
- In 2,421 hospitalized adults with carbon monoxide poisoning, patients with cardiovascular disease history had increased rates of persistent neurological sequelae.
- Cardiovascular disease factors were associated with risk increases reported up to 11.92-fold.
- Overall mortality after carbon monoxide poisoning was 8.8%, compared with 3.7% in the general population, with adjusted mortality 7.40 times higher.
📋 Practice Implication: Discharge planning should identify survivors with cardiovascular disease risk and arrange longitudinal neurologic and cardiovascular follow-up rather than treating recovery as complete at COHb normalization.
|
Scientific reports (2026) - Prospective Observational Study
Key Findings
- Baseline SpCO had reduced agreement with arterial COHb, with moderate concordance only in the moderate COHb range.
- SpCO showed increased positive bias and wide limits of agreement, especially at higher concentrations.
- Agreement was reduced after HBOT and at follow-up in the non-HBOT group, limiting interchangeability with arterial COHb.
📋 Practice Implication: Pulse CO-oximetry can support rapid screening, but arterial COHb should remain the reference for severity classification and post-treatment reassessment.
|
International journal of general medicine (2026) - Retrospective Cohort Study
Key Findings
- Of 272 adults with carbon monoxide poisoning, 103 (37.9%) received HBOT and 169 (62.1%) received normobaric oxygen therapy.
- HBOT recipients had increased cardiac biomarkers and more frequent ischemic ECG findings alongside lower GCS scores.
- Lower GCS had odds ratio 0.66 and ischemic ECG findings had odds ratio 7.31 for HBOT selection, while lactate and COHb had limited discriminative ability.
📋 Practice Implication: HBOT referral decisions should explicitly incorporate neurologic examination and ECG or biomarker evidence of cardiac involvement instead of relying mainly on COHb thresholds.
|
|
💡
Summary
Recent carbon monoxide poisoning literature emphasizes immediate high-flow oxygen, selective hyperbaric oxygen for neurologic, cardiac, pregnancy, or persistent metabolic-risk presentations, and broader risk stratification beyond carboxyhemoglobin alone. The strongest clinical signals support using arterial blood gas markers, neurologic status, cardiac findings, and long-term follow-up planning to reduce missed severity and delayed morbidity.
|
|